Marching for Science, New Opportunities for International Collaboration, and more

Marching for Science

The first March for Science, which took place Saturday, April 22, 2017, in more than 600 locations around the world, drew hundreds of thousands of people. In an effort spearheaded by the American Society of Hematology (ASH), 25 of the world’s leading organizations representing clinicians, laboratory researchers, and physician-scientists expressed support for the nonpartisan event.

A statement issued by ASH and the other medical societies before the march emphasized the importance of scientific evidence, education, and investment to advance health care:

“Every day, physicians make the best patient-care decisions they can by relying on science-based tools. Clinicians prevent disease by administering immunizations, and they manage disease by providing therapies that have been thoroughly and scientifically vetted for optimal outcomes. This science-based care saves lives, decreases human suffering, and reduces unnecessary costs.”

The statement also expressed the need to protect federal investment in health, including research supported by the National Institutes of Health, which has led to significant medical advances, such as genome editing and immunotherapy for cancer treatment. Read the full statement.


ASH Selects First Congressional Fellow

ASH selected Catherine Zander, PhD, to participate in the new ASH Congressional Fellowship program. Dr. Zander is a postdoctoral fellow in the Department of Pathology at the University of Alabama at Birmingham School of Medicine, where she focuses on creating novel treatments for thrombotic thrombocytopenic purpura. Starting in September, Dr. Zander will spend a full academic year in Washington, DC, working in a Congressional office to contribute to health care and hematology policy. She brings experience in research and advocacy to her fellowship role, having served as a representative for the Biophysical Society’s STEM on the Hill day.

The ASH Congressional Fellowship program aims to connect hematologists to the policy-making process and educate Congressional members and staff about issues that are important to hematologists and their patients. Read the full press release.


New Opportunity for International Collaboration: ASH Global Capacity-Building Showcase

To encourage global collaboration, ASH now offers a program for those working to conquer blood diseases worldwide. At the 2017 annual meeting, ASH will showcase capacity-building programs in low- and middle-income countries (LMICs). Participants are invited to prepare a digital poster that highlights the details and results of their program. Please note that these are different from the annual meeting scientific abstracts; information should be submitted in poster format, and selected posters will be displayed digitally at the meeting. Poster submission requirements include at least one author must be from an LMIC, presenters must practice in an LMIC, and posters must focus on research or capacity-building initiatives involving populations in LMICs and include analyses of outcomes from the initiative. The submission deadline is July 17. Please visit hematology.org/globalposters for further instructions.


Registration Open for First AML Matters Summit

AML Matters is an educational program designed to improve the diagnosis and treatment of acute myeloid leukemia (AML). This free event will provide guidance to health-care professionals on the optimal diagnosis and classification of AML, risk stratification, individualized treatment selection, assessment of treatment responses, monitoring for and mitigation of adverse events, and patient education regarding prognosis and treatment choices. The program is geared toward hematology/oncology physicians, advance practice professionals and nurses, hematopathologists/pathologists, hematopoietic cell transplantation clinicians, and other health-care professionals.

Participants can select from the following dates and locations:

  • Minneapolis, MN (July 28, 2017)
  • Durham, NC (October 20, 2017)
  • Philadelphia, PA (October 27, 2017)

ASH Announces Physician-Scientist Career Development Award Recipients

The ASH Physician-Scientist Career Development Award program allows students attending accredited medical schools in the United States or Canada to gain experience in hematology research under the mentorship of an ASH member. Two students have been selected for the 2017-2018 academic year. Mara Rosenberg, of the Oregon Health and Science University in Portland, will study next generation sequencing-based minimal residual disease detection assays for patients with leukemia. Max Brodsky, of Drexel University College of Medicine in Philadelphia, will explore mechanisms of ruxolitinib resistance in JAK2/ASXL1 double-mutant myeloproliferative neoplasms.

From July 1, 2017, through June 30, 2018, they will spend more than 80 percent of their time conducting research and will receive a total award amount of $42,000 to help cover the cost of supplies, insurance, and meeting attendance. Read the full press release.


Abstract Submission Site for 2017 ASH Annual Meeting Opens June 1

The abstract submission site for the 59th ASH Annual Meeting will be open June 1 through August 2. This year’s meeting, which will be held December 9-12 in Atlanta, Georgia, will feature the latest breakthroughs in hematology. Registration and housing open July 19 at 11:00 a.m. EST for ASH members and August 9 at 11:00 a.m. EST for non-members. Visit hematology.org/Annual-Meeting for updated information on abstract submission, program sessions, and new events and activities.


Apply for New Award Program for International Members

The ASH Global Research Award was created especially for trainees and early investigators practicing outside of the United States and Canada, with the goal of supporting future scientific leaders.

Hematologists will receive support during the critical period between completion of training and the establishment of their independent careers. Award amounts will vary and are intended to be flexible based on the project and the costs of the region. The submission deadline for letters of intent is August 31. For more information on eligibility and the application process, visit hematology.org/global-research.aspx.

SHARE